Company / Tangible Book Value per Share
Prime Medicine, Inc. Tangible Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.92
FY2025
5-year range
-$12.04 / $9.76
FY2021-FY2025
Trend
-32.6%
vs FY2024
Sector context
#158 of 209
Health Care
What the data says
Prime Medicine, Inc.'s tangible book value per share of $0.92 is lower than 76% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has declined for 3 consecutive years, from $9.76 in FY2022 to $0.92 in FY2025.
Based on SEC 10-K filings.
0.92 in FY2025 with a 5-year CAGR of +0.8%.
Declined from $1.46 to $0.92 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -54.5%
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- -
Sector benchmark
-99.0% below sector average
Key checks
Key Insights
- Prime Medicine, Inc.'s tangible book value per share has declined for 3 consecutive years.
- In FY2025, tangible book value per share decreased 32.6% year-over-year.
- Ranks #158 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.92 | -32.6% |
| FY2024 | $1.37 | -6.6% |
| FY2023 | $1.46 | -85.0% |
| FY2022 | $9.76 | +181.0% |
| FY2021 | -$12.04 | -1459.7% |
| FY2020 | $0.89 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026